Anna Durrans
Impact in
- Cancer Research top 5%
- Cancer Genomics and Diagnostics
- Cancer-related molecular mechanisms research
- MicroRNA in disease regulation
- Cancer, Hypoxia, and Metabolism
- Oncology top 5%
- Cancer Cells and Metastasis
Papers in ⓘ
-
- MicroRNA in disease regulation 2
- Cancer Genomics and Diagnostics 2
- Cancer, Hypoxia, and Metabolism 2
- Oncology 5
- Cancer Cells and Metastasis 4
- Co-authors
- Dingcheng Gao (5 shared papers)Nasser K. Altorki (6 shared papers)Hyejin Choi (6 shared papers)Vivek Mittal (6 shared papers)Stephen T.C. Wong (4 shared papers)Seongho Ryu (4 shared papers)Fuhai Li (3 shared papers)Jianting Sheng (3 shared papers)
- Journals
- Cancer Research (2 papers)Neoplasia (1 paper)Nature (1 paper)PLoS ONE (1 paper)Cell Reports (1 paper)
- Partner nations
- United StatesSouth Korea
In The Last Decade
Anna Durrans
7 papers receiving 1.6k citations
Hit Papers
Peers
Comparison fields: 5 of 82
- Cancer Research 620
- Oncology 940
- Molecular Biology 972
- Cell Biology 189
- Biotechnology 73
Countries citing papers authored by Anna Durrans
This map shows the geographic impact of Anna Durrans's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Anna Durrans with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Anna Durrans more than expected).
Fields of papers citing papers by Anna Durrans
This network shows the impact of papers produced by Anna Durrans. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Anna Durrans. The network helps show where Anna Durrans may publish in the future.
Co-authors
The 25 scholars most cited alongside Anna Durrans, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | Epithelial-to-mesenchymal transition is not required for lung metastasis but contributes to chemoresistance Hit paper breakdown → | 2015 | 1395 |
| 2 | 2015 | 118 | |
| 3 | 2016 | 48 | |
| 4 | 2010 | 25 | |
| 5 | 2015 | 15 | |
| 6 | 2015 | 4 | |
| 7 | 2014 | 2 |
About Anna Durrans
Anna Durrans is a scholar working on Cancer Research, Oncology, Hepatology, Biotechnology and Cell Biology, having authored 7 papers that have together received 1.6k indexed citations. Recurring topics across this work include Cancer Cells and Metastasis (4 papers), MicroRNA in disease regulation (2 papers), Cancer Genomics and Diagnostics (2 papers), Cancer, Hypoxia, and Metabolism (2 papers), Epigenetics and DNA Methylation (1 paper), Signaling Pathways in Disease (1 paper), RNA modifications and cancer (1 paper) and Liver physiology and pathology (1 paper). The work is most often cited by research in Cancer Research (620 citations), Oncology (940 citations), Molecular Biology (972 citations), Cell Biology (189 citations) and Biotechnology (73 citations). Anna Durrans has collaborated with scholars based in United States and South Korea. Frequent co-authors include Dingcheng Gao, Nasser K. Altorki, Hyejin Choi, Vivek Mittal, Stephen T.C. Wong, Seongho Ryu, Fuhai Li, Jianting Sheng, Kari Fischer and Tina El Rayes. Their work appears in journals such as Cancer Research, Neoplasia, Nature, PLoS ONE and Cell Reports.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.